FLT3 and acute myeloid leukemia: Here, we demonstrate that MRT treatment can synergize with the FLT3 inhibitor, quizartinib, to induce the irreversible differentiation of FLT3-ITD+ AML cell line, similarly to what was observed in ATRA-mediated differentiation.